CSIRTS // UNIFIED SECURITY ADVISORY FEEDSYS ● ONLINE · POWERED BY INTELFUSIONS.COM

CVE-2026-52830: fast-mcp-telegram is a Telegram MCP Server. Prior to 0.19.1, fast-mcp-telegram validates HTTP Bearer tokens by joining the raw token string into a session-file path. The verifier r

criticalCVSS 9.4CVE-2026-52830
fast-mcp-telegram is a Telegram MCP Server. Prior to 0.19.1, fast-mcp-telegram validates HTTP Bearer tokens by joining the raw token string into a session-file path. The verifier rejects the exact reserved token telegram, but it does not reject path separators or normalize the path before checking whether the session file exists. A remote HTTP client can therefore authenticate as the default legacy session with a token such as ../fast-mcp-telegram/telegram when the documented default session file ~/.config/fast-mcp-telegram/telegram.session exists. This bypasses the reserved session name control that is intended to prevent HTTP multi-user sessions from colliding with the default stdio or legacy account. With account-prefixed MCP tools enabled, the attacker still sees and calls the prefixed tools for the default account, so the prefix middleware does not stop the session selection bypass. This vulnerability is fixed in 0.19.1.

Details

Source
NVD Recent CVEs (US · database · site)
Severity
critical — CVSS 9.4
Published
2026-07-02
Last updated
2026-07-06
Exploitation
Not in CISA KEV at last sync

Original advisory: https://nvd.nist.gov/vuln/detail/CVE-2026-52830

Exploitation outlook

EPSS (FIRST.org) estimates each CVE’s probability of exploitation in the next 30 days — here is the CSIRTS.com read on those numbers.

Referenced CVEs

CVECSIRTS overviewExternal
CVE-2026-52830coverage & exploitation statusNVD · CVE.org

Same CVEs, other sources

How other CERTs, PSIRTs and databases cover the vulnerabilities in this advisory.

Recent advisories for fast-mcp-telegram is a

A cluster of recent advisories against the same product widens the attack surface — attackers routinely chain freshly published CVEs on one product, so review these together.

More from NVD Recent CVEs